Laminar Pharmaceuticals S.A. 

The number One Biotech in Spain

OWNER

Pablo Escriba (See Profile)


Sector

Drug Discovery

Stage

Development, market readiness, clinical trial

Country

España


A robust pipeline of medicines in clinical trials

LAM561 in phase 2B/3 has blockbuster potential and is expected to be marketed in 2023 with worldwide patent protection

Laminar is a prolific drug discovery engine with an innovative technology to design safe and efficacious medicaments

Status

Approved

IP Type

Patent

Time

13 years

Countries

USA

Coverage

Composition of matter, medical uses, nutraceutical use, and cosmetic use

Know more of this patent

This information is confidential, do not share or copy.

Under evaluation at least till: April 18th, 2022

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2022 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar